Title: Aarkstore - Regado Biosciences, Inc. - Product Pipeline Review - 2014
1Regado Biosciences, Inc. - Product Pipeline
Review - 2014
Category Pharmaceuticals Healthcare
- Browse Complete Report -
- http//www.aarkstore.com/pharmaceuticals-healthcar
e/63687/regado-biosciences-inc-product-pipeline-re
view
2Regado Biosciences, Inc. - Product Pipeline
Review - 2014
3Summary
- Global Markets Directs, Regado Biosciences,
Inc. - Product Pipeline Review - 2014, provides
an overview of the Regado Biosciences, Inc.s
pharmaceutical research and development
focus. This report provides comprehensive
information on the current therapeutic
developmental pipeline of Regado Biosciences,
Inc.s, complete with comparative analysis at
various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of
administration (RoA) and molecule type. It also
reviews latest updates, and featured news and
press releases, along with special features on
late-stage and discontinued projects. "Regado
Biosciences, Inc. - Product Pipeline Review -
2014"report features investigational drugs from
across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built
using data and information sourced from Global
Markets Directs proprietary databases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team.
4Summary
- Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the
report may be removed or altered based on the
availability and relevance of data for the
indicated disease.
5Scope
- - The report provides brief overview of Regado
Biosciences, Inc. including business description,
key information and facts, and its locations and
subsidiaries - The report reviews current
pipeline of Regado Biosciences, Inc.s human
therapeutic division and enlists all their major
and minor projects - The report features product
description and descriptive mechanism of action
for key pipeline products along with the
products developmental history and major
milestones - Special feature on out-licensed
and partnered product portfolio - The report
summarizes all the dormant and discontinued
pipeline projects - Latest company statement -
Latest news and deals relating to the Regado
Biosciences, Inc.s pipeline products
6Reasons to buy
- - Evaluate Regado Biosciences, Inc.s strategic
position with total access to detailed
information on its product pipeline - Assess the
growth potential of Regado Biosciences, Inc. in
its therapy areas of focus - Identify new drug
targets and therapeutic classes in the Regado
Biosciences, Inc.s RD portfolio and develop key
strategic initiatives to reinforce pipeline in
those areas - Exploit in-licensing opportunities
by identifying windows of opportunity to fill
portfolio gaps - Develop strategic initiatives
by understanding the focus areas of Regado
Biosciences, Inc. and exploit collaboration and
partnership opportunities - Identify emerging
players with potentially strong product portfolio
and create effective counter-strategies to gain
competitive advantage - Plan mergers and
acquisitions effectively by identifying the most
promising pipeline of Regado Biosciences, Inc. -
Develop and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and scope
7Table of Content
List of Tables 3List of Figures 3Regado
Biosciences, Inc. Snapshot 4Regado Biosciences,
Inc. Overview 4Key Information 4Key Facts
4Regado Biosciences, Inc. - Research and
Development Overview 5Key Therapeutic Areas
5Regado Biosciences, Inc. - Pipeline Review
7Pipeline Products by Stage of Development
7Pipeline Products - Monotherapy 8Regado
Biosciences, Inc. - Pipeline Products Glance
9Regado Biosciences, Inc. - Clinical Stage
Pipeline Products 9Phase I Products/Combination
Treatment Modalities 9
8Table of Content
Regado Biosciences, Inc. - Early Stage Pipeline
Products 10Preclinical Products/Combination
Treatment Modalities 10Discovery
Products/Combination Treatment Modalities
11Regado Biosciences, Inc. - Drug Profiles
12REG-2 12Product Description 12Mechanism of
Action 12RD Progress 12REG-3 14Product
Description 14Mechanism of Action 14RD
Progress 14Aptamers for Cardiovascular Diseases
15Product Description 15
9List Of Tables
- Regado Biosciences, Inc., Key Information
4Regado Biosciences, Inc., Key Facts 4Regado
Biosciences, Inc. - Pipeline by Indication, 2014
6Regado Biosciences, Inc. - Pipeline by Stage of
Development, 2014 7Regado Biosciences, Inc. -
Monotherapy Products in Pipeline, 2014 8Regado
Biosciences, Inc. - Phase I, 2014 9Regado
Biosciences, Inc. - Preclinical, 2014 10Regado
Biosciences, Inc. - Discovery, 2014 11Regado
Biosciences, Inc. - Pipeline by Target, 2014
16Regado Biosciences, Inc. - Pipeline by Route
of Administration, 2014 17Regado Biosciences,
Inc. - Pipeline by Molecule Type, 2014 18Regado
Biosciences, Inc. - Pipeline Products by
Mechanism of Action, 2014 19Regado Biosciences,
Inc. - Recent Pipeline Updates, 2014 20Regado
Biosciences, Inc. - Discontinued Pipeline
Products, 2014 21Regado Biosciences, Inc., Other
Locations 22
10List of Figures
- Regado Biosciences, Inc. - Pipeline by Top 10
Indication, 2014 6Regado Biosciences, Inc. -
Pipeline by Stage of Development, 2014 7Regado
Biosciences, Inc. - Monotherapy Products in
Pipeline, 2014 8Regado Biosciences, Inc. -
Pipeline by Top 10 Target, 2014 16Regado
Biosciences, Inc. - Pipeline by Top 10 Route of
Administration, 2014 17Regado Biosciences, Inc.
- Pipeline by Top 10 Molecule Type, 2014
18Regado Biosciences, Inc. - Pipeline Products
by Top 10 Mechanism of Action, 2014 19
11Related Reports
- Global Neurosurgery Market 2015-2019
- Active Pharmaceutical Ingredients (API) Market in
India 2015-2019 - BrainStorm Cell Therapeutics Inc. (BCLI) -
Financial and Strategic SWOT Analysis Review - Ampio Pharmaceuticals, Inc. (AMPE) - Financial
and Strategic SWOT Analysis Review - MiMedx Group, Inc (MDXG) - Financial and
Strategic SWOT Analysis Review
12Related Reports
- Threshold Pharmaceuticals, Inc. (THLD) -
Financial and Strategic SWOT Analysis Review - MEI Pharma, Inc. (MEIP) - Financial and Strategic
SWOT Analysis Review - Titan Pharmaceuticals, Inc. (TTNP) - Financial
and Strategic SWOT Analysis Review - RedHill Biopharma Ltd. (RDHL) - Financial and
Strategic SWOT Analysis Review - Pharmaceuticals Healthcare Market Research
Reports
13- Regado Biosciences, Inc. - Product Pipeline
Review - 2014 Published Oct 2014 24 Pages - "Regado Biosciences, Inc. - Product Pipeline
Review - 2014"report features investigational
drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications.
Price
Format Price
PDF 1500
Site Licence 3000
Enterprise Wide Licence 4500
14Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
- You Can Visit http//www.aarkstore.com
- OR Mail us at contact_at_aarkstore.com
- Blog
- http//www.aarkstore.com/blog/
- Conference
- http//conference.aarkstore.com/
- News
- http//www.aarkstore.com/news